Specific and nonspecific immune responses to Marek's disease virus

Developmental and Comparative Immunology

Volumn 24, Issue 2-3, 2000, Pages 201-221

  Schat, Karel A ^a   Xing, Zheng ^a  

^a College of Veterinary Medicine Cornell University ^*  (United States)

Author keywords

Antiviral immunity; Cell mediated immunity; Herpesvirus; Interferon ; Macrophages, Cytotoxic T cells; Marek's disease; Nitric oxide; Pathogenesis

Indexed keywords

GAMMA INTERFERON; GLYCOPROTEIN; NITRIC OXIDE;

AVIAN LYMPHOMATOSIS HERPETOVIRUS; B LYMPHOCYTE; CYTOTOXIC T LYMPHOCYTE; IMMUNE RESPONSE; INFECTION CONTROL; INFECTION SENSITIVITY; NONHUMAN; PRIORITY JOURNAL; REVIEW; T CELL LYMPHOMA; VIRUS REPLICATION;

AVES; DNA VIRUSES; GALLID HERPESVIRUS 2; GALLUS GALLUS; HERPESVIRIDAE; HERPETOVIRUS; MARDIVIRUS;

EID: 0034163281     PISSN: 0145305X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-305X(99)00073-7     Document Type: Article

References (125)

1. Ricks CA, Avakian A, Bryan T, Gildersleeve R, Haddad E, Ilich R, King S, Murray L, Phelps P, Poston R, Whitfill C, Williams C. In ovo vaccination technology. In: Schultz RD, editor. Veterinary vaccines and diagnostics. Adv. Vet. Med. 1999;41:495-515.
2. Witter R.L. The changing landscape of Marek’s disease. Avian Pathol. 27:1998;S46-53.
3. Witter R.L. Increased virulence of Marek’s disease virus field isolates. Avian Dis. 41:1997;149-163.
4. Calnek B.W., Harris R.W., Buscaglia C., Schat K.A., Lucio B. Relationship between the immunosuppressive potential and the pathotype of Marek’s disease virus isolates. Avian Dis. 42:1998;124-132.
5. Schat K.A. Immunity in Marek’s disease and other tumors. Toivanen A., Toivanen P. Avian immunology: basis and practice. vol. II:1987;101-128 CRC Press, Boca Raton, USA.
6. Schat K.A. Immunity to Marek’s disease, lymphoid leukosis and reticuloendotheliosis. Davison F., Payne L.N., Morris T.R. Poultry Immunology. 1996;209-233 Carfax Publishing Company, Abingdon, England.
7. Calnek B.W., Witter R.L. Marek’s disease. Calnek B.W., Barnes H.J., Beard C.W., McDougald L.R., Saif Y.M. Diseases of poultry. 10th ed:1997;367-413 Iowa State University Press, Ames, USA.
8. Calnek B.W. Lymphomagenesis in Marek’s disease. Avian Pathol. 27:1998;S54-S64.
9. Ross L.J.N. T-cell transformation by Marek’s disease virus. Trends Microbiol. 7:1999;22-29.
10. Roizman B. Herpesviridae. Fields B.N., Knipe D.M., Howley P.M., Chanock R.M., Melnick J.L., Monath T.P., Roizman B., Straus S.E. Fields virology. 3rd ed:1996;2221-2231 Lippencott-Raven Publishers, Philadelphia, USA.
11. Zelnik V. Marek’s disease and new approaches to its control. Acta Virol. 39:1995;53-63.
12. Schat KA. Unpublished data, 1979.
13. Jeurissen S.H.M., Janse E.M., Wagenaar F., de Boer G.F. The role of splenic ellipsoid-associated reticulum cells in the pathogenesis of Marek’s disease. de Boer G.F., Jeurissen S.H.M. Proc. 4th Intl. Symp. Marek’s Disease. 1992;211-215 Ponsen & Looijen, Amsterdam, The Netherlands. Wageningen.
14. Calnek B.W. Marek’s disease - a model for herpesvirus oncology. CRC Crit. Rev. Microbiol. 12:1986;293-320.
15. Schat K.A. Marek’s disease - a model for protection against herpesvirus-induced tumors. Cancer Surveys. 6:1987;1-37.
16. Calnek B.W. Pathogenesis of Marek’s disease. Calnek B.W., Spencer J.L. Proc. Int. Symp. Marek’s Disease. 1985;374-390 American Association of Avian Pathologists, Kennett Square, USA.
17. Baigent S.J., Ross L.J.N., Davison T.F. Differential susceptibility to Marek’s disease is associated with differences in number, but not in phenotype or location, of pp38+ lymphocytes. J. Gen. Virol. 79:1998;2795-2802.
18. Lee S.I., Ohashi K., Morimura T., Sugimoto C., Onuma M. Re-isolation of Marek’s disease virus from T cell subsets of vaccinated and non-vaccinated chickens. Arch. Virol. 144:1999;45-54.
19. Volpini L.M., Calnek B.W., Sekellick M.J., Marcus P.I. Stages of Marek’s disease virus latency defined by variable sensitivity to interferon modulation of viral antigen expression. Vet. Microbiol. 47:1995;99-109.
20. Schat K.A., Chen C.-L.H., Calnek B.W., Char D. Transformation of T-lymphocyte subsets by Marek’s disease herpesvirus. J. Virol. 65:1991;1408-1413.
21. + T-cell-deficient chickens: occurrence of double negative T-cell tumour. Avian Pathol. 26:1997;525-534.
22. Parcells M.S., Dienglewicz R.L., Anderson A.S., Morgan R.W. Recombinant Marek’s disease virus (MDV)-derived lymphoblastoid cell lines: regulation of a marker gene within the context of the MDV genome. J. Virol. 73:1999;1362-1373.
23. Burgess S.C., Kaiser P., Davison T.F. A novel lymphoblastoid surface antigen and its role in Marek’s disease. Silva R.F., Cheng H.H., Coussens P.M., Lee L.F., Velicer L.F. Current research on Marek’s disease. Proc 5th Int. Symp. Marek’s Disease. 1996;29-39 American Association Avian Pathologists, Kennett Square, USA.
24. Schat KA, Davies C. Resistance to viral diseases. In: Axford RFE, Bishop SC, Nicholas FW, Owen JB, editors. Breeding for disease resistance in farm animals. 2nd ed. Wallingford, England: CAB International, p. 271-300.
25. Whitton JL. An overview of antigen presentation and its central role in the immune response. In: Whitton JL, editor. Antigen presentation. Curr. Top Microbiol. Immunol. 1998;232:1-13.
26. Koopmann J-O., Hämmerling G.J., Momburg F. Generation, intracellular transport and loading of peptides associated with MHC class I molecules. Curr. Opin. Immunol. 9:1997;80-89.
27. Busch R., Mellins E.D. Developing and shedding inhibitions; how MHC class II molecules reach maturity. Curr. Opin. Immunol. 8:1996;51-58.
28. Payne L.N., Frazier J.A., Powell P.C. Pathogenesis of Marek’s disease. Int. Rev. Exp. Pathol. 16:1976;59-154.
29. Schat K.A., Calnek B.W., Fabricant J. Characterisation of two highly oncogenic strains of Marek’s disease virus. Avian Pathol. 11:1982;593-605.
30. Lessard M., Hutchings D.L., Spencer J.L., Lillehoj H.S., Gavora J.S. Influence of Marek’s disease virus strain AC-1 on cellular immunity in birds carrying endogenous viral genes. Avian Dis. 40:1996;645-653.
31. Haffer K., Sevoian M., Wilder M. The role of the macrophage in Marek’s disease: in vitro and in vivo studies. Int. J. Cancer. 23:1979;648-656.
32. Bülow von V., Klasen A. Effects of avian viruses on cultured chicken bone-marrow-derived macrophages. Avian Pathol. 12:1983;179-198.
33. Kodama H., Mikami T., Inoue M., Izawa H. Inhibitory effects of macrophages against Marek’s disease virus plaque formation in chicken kidney cell cultures. J. Nat. Cancer Inst. 63:1979;1267-1271.
34. Lee L.F. Macrophage restriction of Marek’s disease virus replication and lymphoma cell proliferation. J. Immunol. 123:1979;1088-1091.
35. Powell P.C., Hartley K.J., Mustill B.M., Rennie M. Studies on the role of macrophages in Marek’s disease of the chicken. J. Ret. Soc. 34:1983;289-297.
36. von Bülow V., Weiler H., Klasen A. Activating effects of interferons, lymphokines and viruses on cultured chicken macrophages. Avian Pathol. 13:1984;621-638.
37. Xing Z, Schat KA. In vitro and in vivo inhibition of Marek’s disease virus by nitric oxide. Immunology (in press).
38. Xing Z, Schat KA. In vitro and in vivo expression of cytokines after infection with Marek’s disease virus, submitted for publication.
39. Lin A.W., Chang C.C., McCormick C.C. Molecular cloning and expression of an avian macrophage nitric oxide synthase cDNA and the analysis of the genomic 5′ flanking region. J. Biol. Chem. 271:1996;11911-11919.
40. Sekellick M.J., Lowenthal J.W., O’Neil T.E., Marcus P.I. Chicken interferon types I and II enhance synergistically the antiviral state and nitric oxide secretion. J. Interf. Cytok. Res. 18:1998;407-414.
41. Xing Z, Schat KA. Unpublished data.
42. Jeurissen S.H.M., Janse E.M. Distribution and function of non-lymphoid cells in liver and spleen of embryonic and adult chickens. Bhogal B.S., Koch G. Recent advances in avian immunology research. 1989;149-157 Alan R. Liss, New York.
43. Hussain I., Qureshi M.A. The expression and regulation of inducible nitric oxide synthase gene differ in macrophages from chickens of different genetic background. Vet. Immunol. Immunopathol. 61:1998;317-329.
44. Lee L.F., Sharma J.M., Nazerian K., Witter R.L. Suppression of mitogen-induced proliferation of normal spleen cells by marcrophages from chickens inoculated with Marek’s disease virus. J. Immunol. 120:1978;1554-1559.
45. Sharma J.M. In vitro suppression of T cell mitogenic response and tumor cell proliferation by spleen macrophages from normal chickens. Infect. Immun. 28:1980;914-922.
46. Xing Z, Schat KA. Nitric oxide production in T cell lines transformed by Marek’s disease virus and reticuloendotheliosis virus, submitted for publication.
47. Fu Y., Blankenhorn E.P. Nitric oxide-induced anti-mitogenic effects in high and low responder rat strains. J. Immunol. 148:1992;2217-2222.
48. Huot A.E., Moore A.L., Roberts J.D., Hacker M.P. Nitric oxide modulates lymphocyte proliferation but not secretion of IL-2. Immunol. Invest. 22:1993;319-327.
49. Pratt W.D., Morgan R.W., Schat K.A. Characterization of reticuloendotheliosis virus-transformed avian T-lymphoblastoid cell lines infected with Marek’s disease virus. J. Virol. 66:1992;7239-7244.
50. Pertile T.L., Sharma J.M., Walser M.M. Reovirus infection in chickens primes splenic adherent macrophages to produce nitric oxide in response to T cell-produced factors. Cell Immunol. 164:1995;207-216.
51. Pertile T.L., Karaca K., Sharma J.M., Walser M.M. Suppressor macrophages mediate depressed lymphoproliferation in chickens infected with avian reovirus. Vet. Immunol. Immunopathol. 53:1996;129-145.
52. Sinha B., Eigler A., Baumann K.H., Greten T.F., Moelletr J., Endres S. Nitric oxide downregulates tumour necrosis factor mRNA in RAW 264.7 cells. Res. Immunol. 149:1998;139-150.
53. Bingisser R.M., Tilbrook P.A., Holt P.G., Kees U.R. Macrophage-derived nitric oxide regulates T cell activation via reversible disruption of the JAK3/STAT5 signaling pathway. J. Immunol. 160:1998;5729-5734.
54. Higgins D.A., Calnek B.W. Some effects of silica treatment on Marek’s disease. Infect. Immun. 13:1976;1054-1060.
55. Gupta M.K., Chauhan H.V.S., Jha G.J., Singh K.K. The role of the reticuloendothelial system in the immunopathology of Marek’s disease. Vet. Microbiol. 20:1989;223-234.
56. Kodama H., Mikami T., Izawa H. Effects of levamisole on pathogenesis of Marek’s disease. JNCI. 65:1980;155-159.
57. Buscaglia C., Calnek B.W., Schat K.A. Effect of reticuloendotheliosis virus and infectious bursal disease virus on Marek’s disease herpesvirus latency. Avian Pathol. 18:1989;265-281.
58. Kim I.J., Karaca K., Pertile T.L., Erickson S.A., Sharma J.M. Enhanced expression of cytokine genes in spleen macrophages during acute infection with infectious bursal disease virus in chickens. Vet. Immunol. Immunopathol. 61:1998;331-341.
59. Nordgren R.M., Stewart-Brown B., Rodenberg J.H. The role of acemannan as an adjuvant for Marek’s disease vaccine. de Boer G.F., Jeurissen S.H.M. Proc. 4th Int. Symp. Marek’s Disease. 1992;165-169 Ponsen & Looijen, Amsterdam, The Netherlands. Wageningen.
60. Karaca K., Sharma J.M., Nordgren R. Nitric oxide production by chicken macrophages activated by acemannan, a complex carbohydrate extracted from Aloe vera. Int. J. Immunopharmac. 17:1995;183-188.
61. Mester J.C., Rouse B.T. The mouse model and understanding immunity to herpes simplex virus. Rev. Inf. Dis. 13:1991;S935-S945.
62. Ross L.J.N. Antiviral T cell-mediated immunity in Marek’s disease. Nature. 268:1977;644-646.
63. Kodama H., Mikami T., Inoue M., Izawa H. Inhibitory effects of macrophages against Marek’s disease virus plaque formation in chicken kidney cell cultures. J. Nat. Cancer Inst. 63:1979;1267-1271.
64. Morimura T., Ohashi K., Sugimoto C., Onuma M. Pathogenesis of Marek’s disease (MD) and possible mechanisms of immunity induced by MD vaccine. J. Vet. Med. Sci. 60:1998;1-8.
65. Schat K.A., Pratt W.D., Morgan R., Weinstock D., Calnek B.W. Stable transfection of reticuloendotheliosis virus-transformed lymphoblastoid cell lines. Avian Dis. 36:1992;432-439.
66. Pratt W.D., Morgan R., Schat K.A. Cell-mediated cytolysis of lymphoblastoid cells expressing Marek’s disease virus-specific phosphoproteins. Vet. Microbiol. 33:1992;93-99.
67. Uni Z., Pratt W.D., Miller M.M., O’Connell P.H., Schat K.A. Syngeneic lysis of reticuloendotheliosis virus-transformed cell lines transfected with Marek’s disease virus genes by virus-specific cytotoxic T cells. Vet. Immun. Immunopath. 44:1994;57-94.
68. Omar A.R., Schat K.A. Syngeneic Marek’s disease virus (MDV)-specific cell-mediated immune responses against immediate early, late, and unique MDV proteins. Virology. 222:1996;87-99.
69. Weinstock D., Schat K.A., Calnek B.W. Cytotoxic T lymphocytes in reticuloendotheliosis virus-infected chickens. Eur. J. Immunol. 19:1989;267-272.
70. Maccubbin D.L., Schierman L. MHC restricted cytotoxic response of chicken T cells: expression, augmentation and clonal expansion. J. Immunol. 136:1986;12-16.
71. Lillehoj H.S., Lillehoj E.P., Weinstock D., Schat K.A. Functional and biochemical characterization of avian T lymphocyte antigens identified by monoclonal antibodies. Eur. J. Immunol. 18:1988;2059-2065.
72. Merkle H., Cihak J., Lösch U. The cytotoxic T cell response in reticuloendotheliosis virus-infected chickens is mediated by αβ and not by γδ T cells. Immunobiol. 186:1992;292-302.
73. Cui Z.-Z., Lee L.-F., Liu J.-L., Kung H.-J. Structural analysis and transcriptional mapping of the Marek’s disease virus gene encoding pp38, an antigen associated with transformed cells. J. Virol. 65:1991;6509-6515.
74. Chen X., Sondermeijer P.J., Velicer L.F. Identification of a unique Marek’s disease virus gene which encodes a 38-kilodalton phosphoprotein and is expressed in both lytically infected and latently infected lymphoblastoid tumor cells. J. Virol. 66:1992;85-94.
75. Ono M., Maeda K., Kawaguchi Y., Jang H.K., Tohya Y., Niikura M., Mikami T. Expression of Marek’s disease virus (MDV) serotype 2 gene which has partial homology with MDV serotype 1 pp38 gene. Virus Res. 35:1995;223-229.
76. Smith G.D., Zelnik V., Ross L.J.N. Gene organization in herpesvirus of turkeys: identification of a novel open reading frame in the long unique region and a truncated homologue of pp38 in the internal repeat. Virology. 207:1995;205-216.
77. Nazerian K., Lee L.F., Yanagida N., Ogawa R. Protection against Marek’s disease by a fowlpox virus recombinant expressing the glycoprotein B of Marek’s disease virus. J. Virol. 66:1992;1409-1413.
78. Omar A.R., Schat K.A., Lee L.F., Hunt H.D. Cytotoxic T lymphocyte response in chickens immunized with a recombinant fowlpox virus expressing Marek’s disease herpesvirus glycoprotein B. Vet. Immunol. Immunopathol. 62:1998;73-82.
79. Omar A.R., Schat K.A. Characterization of Marek’s disease herpesvirus (MDV)-specific cytotoxic T lymphocytes in chickens inoculated with a nononcogenic vaccine strain of MDV. Immunology. 90:1997;579-585.
80. Rouse R.J., Nair S.K., Lydy S.L., Bowen J.C., Rouse B.T. Induction in vitro of primary cytotoxic T-lymphocyte responses with DNA encoding herpes simplex virus proteins. J. Virol. 68:1994;5685-5689.
81. Silva R.F., Lee L.F. Monoclonal antibody-mediated immunoprecipitation of proteins from cells infected with Marek’s disease virus or turkey herpesvirus. Virology. 136:1984;307-320.
82. Seo S.H., Wang L., Smith R., Collison E.W. The carboxyl-terminal 120-residue polypeptide of infectious bronchitis virus nucleocapsid induces cytotoxic T lymphocytes and protects chickens from acute infection. J. Virol. 71:1997;7889-7894.
83. Markowski CJ, O’Connell PH, Schat KA. Unpublished data, 1999.
84. Calnek B.W., Adldinger H.K., Kahn D.E. Feather follicle epithelium: a source of enveloped and infectious cell-free herpesvirus from Marek’s disease. Avian Dis. 14:1970;219-233.
85. Calnek B.W. Antibody development in chickens exposed to Marek’s disease virus. Biggs P.M., de-Thé G., Payne L.N. Oncogenesis and herpesviruses. 1972;129-136 International Agency for Research on Cancer, Lyon, France.
86. Ross N., O’Sullivan G., Coudert F. Influence of chicken genotype on protection against Marek’s disease by a herpesvirus of turkeys recombinant expressing the glycoprotein B (gB) of Marek’s disease virus. Vaccine. 14:1996;187-189.
87. Biron C.A. Activation and function of natural killer cell responses during viral infection. Curr. Opin. Immunol. 9:1997;24-34.
88. Ding A.H.J., Lam K.M. Enhancement by interferon of chicken splenocyte natural killer cell activity against Marek’s disease. Vet. Immunol. Immunopath. 11:1986;65-72.
89. Sekellick M.J., Ferrandino A.F., Hopkins D.A., Marcus P.I. Chicken interferon gene: cloning, expression and analysis. J. Interferon. Res. 14:1994;71-79.
90. Jia W, Schat KA. Unpublished data, 1998.
91. Kaufman J. Structure and function of the major histocompatibility complex of chickens. Davison F., Payne L.N., Morris T.R. Poultry immunology. 1996;67-82 Carfax Publishing Company, Abingdon, England.
92. Kaufman J., Venugopal K. The importance of MHC for Rous sarcoma virus and Marek’s disease virus: some ’Payne-ful’ considerations. Avian Path. 27:1998;S82-S87.
93. Sharma J.M. Natural killer cell activity in chickens exposed to Marek’s disease virus: inhibition of activity in susceptible chickens and enhancement of activity in resistant and susceptible chickens. Avian Dis. 25:1981;882-893.
94. Chausse A.M., Bernardet N., Musset E., Thoraval P., Vaino O., Dambrine G., Coudert F. Expression of MHC class I antigens following Marek’s disease infection. Davison T.F., Bumstead N., Kaiser P. Adv. Avian Immunol. Res. 1995;135-140 Carfax Publishing Company, Abingdon, England.
95. Ploegh H.L. Viral strategies of immune evasion. Science. 280:1998;248-253.
96. Johnson DC, Hill AB. Herpesvirus evasion of the immune system. In: Whitton JL, editor. Antigen presentation. Curr. Top Microbiol. Immunol. 1998;232:149-177.
97. Neipel F., Albrecht J-C., Fleckenstein B. Cell-homologous genes in the Kaposi’s sarcoma-associated rhadinovirus human herpesvirus 8: determinants of its pathogenicity. J. Virol. 71:1997;4187-4192.
98. + T cell response. J. Exp. Med. 187:1998;341-348.
99. Liu J.-L., Lin S.-F., Xia L., Brunovskis P., Li D., Davidson I., Lee L.F., Kung H.-J. MEQ and v-IL8: cellular genes in disguise? Acta. Virol. 43:1999;94-101.
100. + T cells. J. Leukoc. Biol. 59:1996;407-411.
101. Tani K., Su S.B., Utsunomiya I., Oppenheim J.J., Wang J.M. Interferon-gamma maintains the binding and functional capacity of receptors for IL-8 on cultured human T cells. Eur. J. Immunol. 28:1998;502-507.
102. + T lymphocytes: a process regulated by interleukin 10. Biochem. Biophys. Res. Commun. 210:1995;660-669.
103. O’Brien V. Viruses and apoptosis. J. Gen. Virol. 79:1998;1833-1845.
104. Morimura T., Ohashi K., Kon Y., Hattori M., Sugimoto C., Onuma M. Apoptosis and CD8-down-regulation in the thymus of chickens infected with Marek’s disease virus. Arch Virol. 141:1996;2243-2249.
105. Morimura T., Hattori M., Ohashi K., Sugimoto C., Onuma M. Immunomodulation of peripheral T cells in chickens infected with Marek’s disease virus: involvement in immunosuppression. J. Gen. Virol. 76:1995;2979-2985.
106. Xing Z, Schat KA. Unpublished data, 1999.
107. Shek W.R., Calnek B.W., Schat K.A., Chen C.H. Characterization of Marek’s disease virus-infected lymphocytes: discrimination between cytolytically and latently infected cells. J. Natl. Cancer Inst. 70:1983;485-491.
108. Muscarella D.E., Bloom S.E. Involvement of gene-specific DNA damage and apoptosis in the differential toxicity of mitomycin C analogs towards B-lineage versus T-lineage lymphoma cells. Biochem. Pharm. 53:1997;811-822.
109. Liu J.L., Ye Y., Lee L.F., Kung H.J. Transforming potential of the herpesvirus oncoprotein MEQ: morphological transformation, serum-independent growth, and inhibition of apoptosis. J. Virol. 72:1998;388-395.
110. Peng Q., Shirazi Y. Characterization of the protein product encoded by a splicing variant of the Marek’s disease virus Eco-Q gene (Meq). Virology. 226:1996;77-82.
111. Burgess S, Davison F. Unpublished data quoted by Ross [9].
112. + cells carrying a novel lymphoid marker, AV37, in Marek’s disease lymphomas. J. Gen. Virol. 78:1997;2191-2198.
113. Pratt W.D., Cantello J., Morgan R.W., Schat K.A. Enhanced expression of the Marek’s disease virus-specific phosphoprotein after stable transfection of MSB-1 cells with the Marek’s disease homologue of ICP4. Virology. 201:1994;132-136.
114. Volpini L.M., Calnek B.W., Sneath B., Sekellick M.J., Marcus P.I. Interferon modulation of Marek’s disease virus genome expression in chicken cell lines. Avian Dis. 40:1996;78-87.
115. Liu J.-L., Ye Y., Qian Z., Qian Y., Templeton D.J., Lee L.F., Kung H.-J. Functional interactions between herpesvirus oncoprotein MEQ and cell cycle regulator CDK2. J. Virol. 73:1999;4208-4219.
116. Cui Z., Qin A. Immunodepressive effects of the recombinant 38 kd phosphorylated protein of Marek’s disease virus. Silva R.F., Cheng H.H., Coussens P.M., Lee L.F., Velicer L.F. Current research on Marek’s disease. Proc. 5th Int. Symp. Marek’s Disease. 1996;278-283 American Association Avian Pathologists, Kennett Square, USA.
117. Powell P.C., Davison T.F. Induction of Marek’s disease in vaccinated chickens by treatment with betamethasone or corticosterone. Israel J. Vet. Med. 42:1986;73-78.
118. Markowski CJ, O’Connell PH, Schat KA. Manuscript in preparation.
119. Adair B.M., McNulty M.S. Lymphocyte transformation and lymphokine production during chicken anaemia virus infection. Schijns V., Horzinek M.C. Cytokines in veterinary medicine. 1997;301-310 CAB International, Wallingford, UK.
120. Schat K.A., Calnek B.W., Fabricant J. Influence of the bursa of Fabricius on the pathogenesis of Marek’s disease. Infect. Immun. 31:1981;199-207.
121. Calnek B.W., Schat K.A., Heller E.D., Buscaglia C. In vitro infection of T-lymphoblasts with Marek’s disease virus. Calnek B.W., Spencer J.L. Proc. Int. Symp. Marek’s Disease. 1985;173-187 American Association of Avian Pathologists, Kennett Square, USA.
122. Baigent S.J., Ross L.J.N., Davison T.F. A flow cytometric method for identifying Marek’s disease virus pp38 expression in lymphocyte subpopulations. Avian Path. 25:1996;255-268.
123. Eerola W., Veromaa T., Toivanen P. Special features in the structural organization of the avian lymphoid system. Toivanen A., Toivanen P. Avian immunology: basis and practice. vol. I:1987;9-22 CRC Press, Boca Raton, USA.
124. Kaplan S, Calnek BW, Schat KA. Unpublished data, 1998.
125. Schat K.A. Characteristics of the virus. Payne L.N. Marek’s disease: scientific basis and methods of control. 1985;77-112 Martinus Nijhoff Publishing, Boston, USA.